Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
07 2021
Historique:
received: 04 10 2020
accepted: 11 02 2021
revised: 11 02 2021
pubmed: 8 4 2021
medline: 13 8 2021
entrez: 7 4 2021
Statut: ppublish

Résumé

Proline Rich 12 (PRR12) is a gene of unknown function with suspected DNA-binding activity, expressed in developing mice and human brains. Predicted loss-of-function variants in this gene are extremely rare, indicating high intolerance of haploinsufficiency. Three individuals with intellectual disability and iris anomalies and truncating de novo PRR12 variants were described previously. We add 21 individuals with similar PRR12 variants identified via matchmaking platforms, bringing the total number to 24. We observed 12 frameshift, 6 nonsense, 1 splice-site, and 2 missense variants and one patient with a gross deletion involving PRR12. Three individuals had additional genetic findings, possibly confounding the phenotype. All patients had developmental impairment. Variable structural eye defects were observed in 12/24 individuals (50%) including anophthalmia, microphthalmia, colobomas, optic nerve and iris abnormalities. Additional common features included hypotonia (61%), heart defects (52%), growth failure (54%), and kidney anomalies (35%). PrediXcan analysis showed that phecodes most strongly associated with reduced predicted PRR12 expression were enriched for eye- (7/30) and kidney- (4/30) phenotypes, such as wet macular degeneration and chronic kidney disease. These findings support PRR12 haploinsufficiency as a cause for a novel disorder with a wide clinical spectrum marked chiefly by neurodevelopmental and eye abnormalities.

Identifiants

pubmed: 33824499
doi: 10.1038/s41436-021-01129-6
pii: S1098-3600(21)05035-8
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1234-1245

Références

Boycott, K. M. et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am. J. Hum. Genet. 100, 695–705, https://doi.org/10.1016/j.ajhg.2017.04.003 (2017).
doi: 10.1016/j.ajhg.2017.04.003 pubmed: 28475856 pmcid: 5420351
Retterer, K. et al. Clinical application of whole-exome sequencing across clinical indications. Genet. Med. 18, 696–704, https://doi.org/10.1038/gim.2015.148 (2016).
doi: 10.1038/gim.2015.148 pubmed: 26633542
Trujillano, D. et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur. J. Hum. Genet. 25, 176–182, https://doi.org/10.1038/ejhg.2016.146 (2017).
doi: 10.1038/ejhg.2016.146 pubmed: 27848944 pmcid: 27848944
Dillon, O. J. et al. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders. Eur. J. Hum. Genet. 26, 644–651, https://doi.org/10.1038/s41431-018-0099-1 (2018).
doi: 10.1038/s41431-018-0099-1 pubmed: 29453417 pmcid: 5945679
Sobreira, N. L. M. et al. Matchmaker Exchange. Curr. Protoc. Hum. Genet. 95, 9.31.1–9.31.15, https://doi.org/10.1002/cphg.50 (2017).
doi: 10.1002/cphg.50
Au, P. Y. B. et al. GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK. Hum. Mutat. 36, 1009–1014, https://doi.org/10.1002/humu.22837 (2015).
doi: 10.1002/humu.22837 pubmed: 26173930 pmcid: 4589226
O’Donnell-Luria, A. H. et al. Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy. Am. J. Hum. Genet. 104, 1210–1222, https://doi.org/10.1016/j.ajhg.2019.03.021 (2019).
doi: 10.1016/j.ajhg.2019.03.021 pubmed: 31079897 pmcid: 6556837
Bruel, A.-L. et al. 2.5 years’ experience of GeneMatcher data-sharing: a powerful tool for identifying new genes responsible for rare diseases. Genet. Med. 21, 1657–1661, https://doi.org/10.1038/s41436-018-0383-z (2019).
doi: 10.1038/s41436-018-0383-z pubmed: 30563986
Leduc, M. S. et al. De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities. Hum. Genet. 137, 257–264, https://doi.org/10.1007/s00439-018-1877-0 (2018).
doi: 10.1007/s00439-018-1877-0 pubmed: 29556724
Córdova-Fletes, C. et al. A de novo t(10;19)(q22.3;q13.33) leads to ZMIZ1/PRR12 reciprocal fusion transcripts in a girl with intellectual disability and neuropsychiatric alterations. Neurogenetics. 16, 287–298, https://doi.org/10.1007/s10048-015-0452-2 (2015).
doi: 10.1007/s10048-015-0452-2 pubmed: 26163108
Miller, J. A. et al. Transcriptional landscape of the prenatal human brain. Nature. 508, 199–206, https://doi.org/10.1038/nature13185 (2014).
doi: 10.1038/nature13185 pubmed: 24695229 pmcid: 4105188
Bult, C. J., Blake, J. A., Smith, C. L., Kadin, J. A., Richardson, J. E. & Mouse Genome Database Group. Mouse Genome Database (MGD) 2019. Nucleic Acids Res. 47, D801–D806, https://doi.org/10.1093/nar/gky1056 (2019).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 581, 434–443, https://doi.org/10.1038/s41586-020-2308-7 (2020).
doi: 10.1038/s41586-020-2308-7 pubmed: 32461654 pmcid: 7334197
Sobreira, N., Schiettecatte, F., Valle, D. & Hamosh, A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 36, 1928–1930, https://doi.org/10.1002/humu.22844 (2015).
doi: 10.1002/humu.22844
Gu, S. et al. Mechanisms for complex chromosomal insertions. PLoS Genet. 12, e1006446, https://doi.org/10.1371/journal.pgen.1006446 (2016).
doi: 10.1371/journal.pgen.1006446 pubmed: 27880765 pmcid: 5120786
Tapial, J. et al. An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Res. 27, 1759–1768, https://doi.org/10.1101/gr.220962.117 (2017).
doi: 10.1101/gr.220962.117 pubmed: 28855263 pmcid: 5630039
Firth, H. V. et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am. J. Hum. Genet. 84, 524–533, https://doi.org/10.1016/j.ajhg.2009.03.010 (2009).
doi: 10.1016/j.ajhg.2009.03.010 pubmed: 19344873 pmcid: 2667985
Mirzaa, G. et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 1, e87623 (2016).
Stolerman, E. S. et al. Genetic variants in the KDM6B gene are associated with neurodevelopmental delays and dysmorphic features. Am. J. Med. Genet. A. 179, 1276–1286, https://doi.org/10.1002/ajmg.a.61173 (2019).
doi: 10.1002/ajmg.a.61173 pubmed: 31124279
Unlu, G. et al. GRIK5 genetically regulated expression associated with eye and vascular phenomes: discovery through iteration among biobanks, electronic health records, and zebrafish. Am. J. Hum. Genet. 104, 503–519, https://doi.org/10.1016/j.ajhg.2019.01.017 (2019).
doi: 10.1016/j.ajhg.2019.01.017 pubmed: 30827500 pmcid: 6407495
Reis, L. M. et al. Dominant variants in PRR12 result in unilateral or bilateral complex microphthalmia. Clin. Genet. https://doi.org/10.1111/cge.13897 (2020).
Fishilevich, S. et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database (Oxford). 2017, bax028 (2017).
Zerbino, D. R. et al. Ensembl 2018. Nucleic Acids Res. 46, D754–D761, https://doi.org/10.1093/nar/gkx1098 (2018).
doi: 10.1093/nar/gkx1098 pubmed: 29155950
Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 125, 315–326, https://doi.org/10.1016/j.cell.2006.02.041 (2006).
doi: 10.1016/j.cell.2006.02.041 pubmed: 16630819
Harikumar, A. & Meshorer, E. Chromatin remodeling and bivalent histone modifications in embryonic stem cells. EMBO Rep. 16, 1609–1619, https://doi.org/10.15252/embr.201541011 (2015).
doi: 10.15252/embr.201541011 pubmed: 26553936 pmcid: 4693513
Nagase, T. et al. Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 6, 337–345, https://doi.org/10.1093/dnares/6.5.337 (1999).
doi: 10.1093/dnares/6.5.337 pubmed: 10574462
Havugimana, P. C. et al. A census of human soluble protein complexes. Cell. 150, 1068–1081, https://doi.org/10.1016/j.cell.2012.08.011 (2012).
doi: 10.1016/j.cell.2012.08.011 pubmed: 22939629 pmcid: 3477804
Kim, B. R. et al. Identification of the SOX2 interactome by BioID reveals EP300 as a mediator of SOX2-dependent squamous differentiation and lung squamous cell carcinoma growth. Mol. Cell. Proteomics. 16, 1864–1888, https://doi.org/10.1074/mcp.M116.064451 (2017).
doi: 10.1074/mcp.M116.064451 pubmed: 28794006 pmcid: 5629269
Giurato, G. et al. Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells. Sci Data. 5, 180031, https://doi.org/10.1038/sdata.2018.31 (2018).
doi: 10.1038/sdata.2018.31 pubmed: 29509190 pmcid: 5839158
Fountain, M. D. et al. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies. Genet. Med. 21, 1797–1807 (2019).
Ragge, N. K. et al. SOX2 anophthalmia syndrome. Am. J. Med. Genet. A. 135, 1–7, https://doi.org/10.1002/ajmg.a.30642 (2005). discussion 8.
doi: 10.1002/ajmg.a.30642 pubmed: 15812812
Baetens, D. et al. Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development. Genet. Med. 20, 717–727, https://doi.org/10.1038/gim.2017.163 (2018).
doi: 10.1038/gim.2017.163 pubmed: 29261182
Balci, T. B. et al. Debunking Occam’s razor: diagnosing multiple genetic diseases in families by whole-exome sequencing. Clin. Genet. 92, 281–289, https://doi.org/10.1111/cge.12987 (2017).
doi: 10.1111/cge.12987 pubmed: 28170084
Posey, J. E. et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N. Engl. J. Med. 376, 21–31, https://doi.org/10.1056/NEJMoa1516767 (2017).
doi: 10.1056/NEJMoa1516767 pubmed: 27959697
de Geus, C. M. et al. Guidelines in CHARGE syndrome and the missing link: cranial imaging. Am. J. Med. Genet. C Semin. Med. Genet. 175, 450–464, https://doi.org/10.1002/ajmg.c.31593 (2017).
doi: 10.1002/ajmg.c.31593 pubmed: 29168326 pmcid: 5765497
Andreou, A. M. et al. TBX22 missense mutations found in patients with X-linked cleft palate affect DNA binding, sumoylation, and transcriptional repression. Am. J. Hum. Genet. 81, 700–712, https://doi.org/10.1086/521033 (2007).
doi: 10.1086/521033 pubmed: 17846996 pmcid: 2227921
Al-Baradie, R. et al. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am. J. Hum. Genet. 71, 1195–1199, https://doi.org/10.1086/343821 (2002).
doi: 10.1086/343821 pubmed: 12395297 pmcid: 385096
Obayashi, T., Kagaya, Y., Aoki, Y., Tadaka, S. & Kinoshita, K. COXPRESdb v7: a gene coexpression database for 11 animal species supported by 23 coexpression platforms for technical evaluation and evolutionary inference. Nucleic Acids Res. 47, D55–D62, https://doi.org/10.1093/nar/gky1155 (2019).
doi: 10.1093/nar/gky1155 pubmed: 30462320
Jiao, X. et al. DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics. 28, 1805–1806, https://doi.org/10.1093/bioinformatics/bts251 (2012).
doi: 10.1093/bioinformatics/bts251 pubmed: 22543366 pmcid: 3381967
Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 325, 834–840, https://doi.org/10.1126/science.1175371 (2009).
doi: 10.1126/science.1175371 pubmed: 19608861

Auteurs

Fuad Chowdhury (F)

Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada.

Lei Wang (L)

Baylor Genetics Laboratory, Houston, TX, USA.

Mohammed Al-Raqad (M)

Al-Balqa Applied University, Faculty of Medicine, Al-Salt, Jordan.

David J Amor (DJ)

Murdoch Children's Research Institute and University of Melbourne Department of Paediatrics, Royal Children's Hospital, Parkville, Australia.

Alice Baxová (A)

Department of Biology and Medical Genetics, 1st Faculty of Medicine and University Hospital, Charles University, Prague, Czech Republic.

Šárka Bendová (Š)

Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.

Elisa Biamino (E)

Department of Pediatrics, Regina Margherita Children Hospital, Turin, Italy.

Alfredo Brusco (A)

Department of Medical Sciences, University of Torino, Torino, Italy.

Oana Caluseriu (O)

Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.

Nancy J Cox (NJ)

Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.

Tawfiq Froukh (T)

Department of Biotechnology and Genetic Engineering, Philadelphia University, Amman, Jordan.

Meral Gunay-Aygun (M)

Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

Miroslava Hančárová (M)

Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.

Devon Haynes (D)

Division of Genetics, Arnold Palmer Hospital for Children-Orlando Health, Orlando, FL, USA.

Solveig Heide (S)

Département de Génétique and CRMR « Déficience Intellectuelle », Hôpital de la Pitié Salpêtrière, APHP Sorbonne Université, Paris, France.

George Hoganson (G)

Department of Medical Genetics, Mercyhealth-Javon Bea Hospital, Rockford, IL, USA.

Tadashi Kaname (T)

Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.

Boris Keren (B)

Département de Génétique and CRMR « Déficience Intellectuelle », Hôpital de la Pitié Salpêtrière, APHP Sorbonne Université, Paris, France.

Kenjiro Kosaki (K)

Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.

Kazuo Kubota (K)

Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.

Jennifer M Lemons (JM)

Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Maria A Magriña (MA)

Medical Specialties Unit from City Hall São Jose dos Campos, São Paulo, Brazil.

Paul R Mark (PR)

Division of Medical Genetics and Genomics, Spectrum Health, Grand Rapids, MI, USA.

Marie T McDonald (MT)

Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA.

Sarah Montgomery (S)

Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA.

Gina M Morley (GM)

Department of Medical Genetics, Mercyhealth-Javon Bea Hospital, Rockford, IL, USA.

Hidenori Ohnishi (H)

Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan.

Nobuhiko Okamoto (N)

Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.

David Rodriguez-Buritica (D)

Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Patrick Rump (P)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Zdeněk Sedláček (Z)

Department of Biology and Medical Genetics, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.

Krista Schatz (K)

Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

Haley Streff (H)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

Tomoko Uehara (T)

Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.

Jagdeep S Walia (JS)

Department of Pediatrics, Division of Medical Genetics, Kingston General Hospital, Kingston, ON, Canada.

Patricia G Wheeler (PG)

Division of Genetics, Arnold Palmer Hospital for Children-Orlando Health, Orlando, FL, USA.

Antje Wiesener (A)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Koichi Kawakami (K)

Laboratory of Molecular and Developmental Biology, National Institute of Genetics, Mishima, Japan.

Ingrid M Wentzensen (IM)

GeneDx, Gaithersburg, MD, USA.

Seema R Lalani (SR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

Victoria M Siu (VM)

Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada.
Children's Health Research Institute, London, ON, Canada.

Weimin Bi (W)

Baylor Genetics Laboratory, Houston, TX, USA. wbi@bcm.edu.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. wbi@bcm.edu.

Tugce B Balci (TB)

Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. Tugce.Balci@lhsc.on.ca.
Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, ON, Canada. Tugce.Balci@lhsc.on.ca.
Children's Health Research Institute, London, ON, Canada. Tugce.Balci@lhsc.on.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH